Market Place
Sourcing Support
PhaseBio Names Jonathan Birchall as Chief Commercial Officer
18 Nov 2021 //
BUSINESSWIRE
Seagen undaunted by AstraZeneca-Daiichi`s Enhertu
30 Oct 2021 //
FIERCEPHARMA
Canada`s Xenon touts win for its daily epilepsy pill
05 Oct 2021 //
ENDPTS
AstraZeneca`s Enhertu gets BTD for breast cancer; Centessa nabs $300M loan
05 Oct 2021 //
ENDPTS
AZ-Daiichi, Biogen-Samsung, Clover and more—Fierce Pharma Asia
24 Sep 2021 //
FIERCEPHARMA
Enhertu delivers massive progression edge over Kadcyla
20 Sep 2021 //
FIERCEPHARMA
Genentech`s Biological Ado-Trastuzumab Emtansine Receives Approval In US
27 Sep 2020 //
FDA
Chugai Obtains Approval for Additional Indication of Kadcyla
21 Aug 2020 //
CHUGAI-PHARM.CO
Chuagi gets Japanese additional indication approval for Kadcyla
21 Aug 2020 //
PHARMABIZZ
Final NHS green light for Roche`s Kadcyla
10 Jun 2020 //
PHARMATIMES
EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla
18 Dec 2019 //
PMLIVE
As Biosimilars Emerge in Oncology and Rare Disease
17 Oct 2019 //
CENTERFORBIOSIMILARS
Seattle Genetics Announces start of Phase 3 Clinical Trial of T-DM1, Kadcyla®
11 Oct 2019 //
BUSINESS WIRE
Biosimilars will leave a $10B gap in Roche`s sales: exec
18 Sep 2019 //
FIERCE PHARMA
Chugai seeks new Kadcyla indication in Japan
30 Aug 2019 //
THE PHARMALETTER
Roche`s New Cancer, MS Drugs Pay Off With a Forecast Boost
18 Apr 2019 //
BLOOMBERGQUINT
Roche`s drugs, new and old, team up for major sales
17 Apr 2019 //
FIERCE PHARMA
Roche makes case for expanded Kadcyla use
06 Feb 2019 //
ENDPTS
Roche nabs FDA review to expand Kadcyla in breast cancer
05 Feb 2019 //
Roche submits sBLA to FDA for Kadcyla
05 Feb 2019 //
PRESS RELEASE
Roche adapts newer breast cancer drug in face of Herceptin imitations
05 Feb 2019 //
REUTERS
Genentech`s Kadcyla(Ado-Trastuzumab Emtansine) Receives Approval US
18 Dec 2018 //
FDA
Roche’s Kadcyla cut the risk of disease recurring by half compared to Herceptin
05 Dec 2018 //
PRESS RELEASE
Roche’s Kadcyla shows promise in early breast cancer
16 Oct 2018 //
PHARMA TIMES
Filing of Lawsuit on Patent Infringement Concerning Herceptin® Injection
13 Oct 2018 //
PRESS RELEASE
FDA Clears Mersana to Restart Cancer Drug Trial With New Safeguards
17 Sep 2018 //
XCONOMY
ODAC’s approval takes us one step closer to USFDA nod trastuzumab: Biocon’s CMD
14 Jul 2017 //
MONEYCONTROL
Breast cancer drug Kadcyla to be routinely available in Wales
27 Jun 2017 //
PHARMACEUTICAL JOURNAL
NICE, Roche Reach Deal on Breast Cancer Drug
16 Jun 2017 //
RAPS
SMC u-turn backs Roche’s Kadcyla for breast cancer
12 Apr 2017 //
PHARMA TIMES
Roche`s Lucentis Gets FDA Nod for Fifth Indication
06 Jan 2017 //
NASDAQ
NICE Backs Roche’s Perjeta, but Bars Kadcyla
04 Jan 2017 //
PHARMATIMES
Breast Cancer Drug Rejected for NHS use on Cost-benefit Grounds
29 Dec 2016 //
THE GUARDIAN
Pfizer Nimenrix Vaccine`s Label Expanded in the EU
22 Dec 2016 //
NASDAQ
Roche`s Investors Remain Cautious Despite Improving Business
07 Dec 2016 //
FORBES
Eisai wins NICE backing for older Halaven but still isn`t happy about Lenvima
03 Nov 2016 //
FIERCE PHARMA
Roche Bid for Avastin Follow-on Suffers Blow with Trial Failure
22 Oct 2016 //
REUTERS
Roche`s First-Quarter Sales Fueled by Breast Cancer Trio
19 Apr 2016 //
BLOOMBERG
Roche Seeks to Avoid Cancer-Drug Drama With U.K. Price Talks
02 Apr 2016 //
BLOOMBERG
Roche shares slip as profits miss expectations
29 Jan 2016 //
PM LIVE
Roche Sales Beat Estimates on New Breast-Cancer Treatments
28 Jan 2016 //
BLOOMBERG
Bristol-Myers` Opdivo Gets Nod for Melanoma From U.K. Regulator
22 Jan 2016 //
BLOOMBERG
Roche Discount Fails to Win Breast-Cancer Drug Backing in U.K.
16 Dec 2015 //
BLOOMBERG
NHS patients barred from BMS` Opdivo, Roche`s Kadcyla
15 Dec 2015 //
PHARMATIMES
Roche challenges hometown rival Novartis with new targeted med Alecensa
14 Dec 2015 //
FIERCE PHARMA MARKETING
Pfizer`s Ibrance pricing shows multiyear market analysis
09 Dec 2015 //
FIERCE PHARMA
Swiss drugmaker Roche launches costliest cancer drugs in India
25 Nov 2015 //
ECONOMIC TIMES
Roche breast cancer drug at center of UK pricing row
17 Nov 2015 //
REUTERS
Breast cancer drug Kadcyla to remain on NHS after manufacturer lowers price
06 Nov 2015 //
THE GUARDIAN
Roche team develops armed antibody in antibiotic fight
05 Nov 2015 //
REUTERS
British cancer drugs fund changes tack: again
04 Nov 2015 //
REUTERS
In snit over supply, MSF urges South Africa to override AbbVie drug patent
03 Nov 2015 //
FIERCE PHARMA
Roche plans to step up India play, launches two new medicines
08 Oct 2015 //
ECONOMIC TIMES
Call for Britain to over-ride patents on Roche cancer drug
02 Oct 2015 //
REUTERS
Roche CEO lashes out at U.K.`s `stupid` move to stop paying for a dozen-plus cancer meds
08 Sep 2015 //
FIERCE PHARMA
Zymeworks Announces Bi-Specific Antibody Collaboration with Celgene
21 Jan 2015 //
ZYMEWORKS
